DUBLIN--(BUSINESS WIRE)--The "Smart Pills Drug Delivery Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
Global Smart Pills Drug Delivery market is expected to witness a CAGR of 11.5% during the forecast period.
Certain factors that are driving the market growth include increasing preference for minimally invasive devices, increasing incidence of gastrointestinal disorders, and technological advancements.
There are various technological advancements in smart pills in recent years. For instance, Novartis partnered with Proteus and developed a sensory enabled smart pill, which once swallowed can gather the information that can be used to diagnose patients.
In addition, Australian researchers developed an electronic capsule, which is designed to analyze the composition of the gas in the small and large intestine and send the data to an external device in 5-minute intervals.
In 2018, the researchers revealed that they used a wireless capsule equipped with sensors, battery, and a radio transmitter for monitoring the production of gas in the human digestive tract. The pill can also detect the levels of oxygen, hydrogen, and carbon dioxide.
Due to the advancement of these technologies, patients are likely to adopt these smart pills for more efficient care and treatment, which is expected to augment the growth of the market.
Capsule Endoscopy is Expected to Hold Significant Market Share in the Type Segment
With the advents in healthcare technology, smart pills are capable of eliminating the need for invasive procedures. The wireless communication of smart pills allows understanding of the real- time information. Various advances are being undertaken in the smart pills, such as advances in batteries and on-board memory, which are making them significant for long-term usage. It is expected that smart pills will become an integral part of remote patient monitoring and telemedicine.
National Institute of Health has stated that the advancements in capsule endoscopy are being done rapidly, and in the near future, with an interface application, doctors will be able to control the movement of the device, inside the body. Through this technique, they can easily inspect or diagnose the point of the area, in the body. Hence, with the continuous advancements that are being done in the area of endoscopy, and with the rising need for proper diagnosis of the gastrointestinal disorders, it is believed that the market studied will have a rapid growth, over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
There are about 1.6 million Americans that are found to have inflammatory bowel diseases (IBD). This includes about 780,000 people with Crohn's disease and another 907,000 people with ulcerative colitis. Researchers have estimated that there are 6 to 15 new cases of Crohn's disease that are diagnosed per 100,000 people, each year. Therefore, the increasing prevalence of gastrointestinal disorders is anticipated to fuel the market, over the forecast period.
There is also vast research being conducted, for instance, the US researchers have developed an ingestible capsule that can be controlled wirelessly, to deliver drugs. The scientists from the Massachusetts Institute of Technology and Brigham and Women's Hospital developed a capsule that can be customized to deliver drugs and can sense environmental conditions. 3-D printing technology is being used to manufacture these capsules, which could be used to treat various diseases.
These smart capsules could also be designed to sense infections, allergic reactions, or other events, and then release a drug in response. Hence, all these factors contribute to the increasing research that will be responsible for driving the overall market.
The global Smart Pills Drug Delivery market is highly competitive and consists of a few major players. Companies like CapsoVision, Check- Cap, etectRx Inc., HQ Inc., Jinshan Science and Technology, Koninklijke Philips NV (Medimetrics), Medtronic PLC, Olympus Medical Technology, Otsuka Pharmaceutical Co. Ltd, Proteus Pharmaceuticals, and Intromedic, among others, hold the substantial market share in the Smart Pills Drug Delivery market.
Key Topics Covered
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Preference for Minimally Invasive Devices
4.2.2 Increasing Incidence of Gastrointestinal Disorders
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Stringent Regulations for the Approval of Smart Pills
4.3.2 Potential Health Risk
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1.1 Capsule Endoscopy
5.1.2 Patient Monitoring
5.1.3 Drug and Delivery Systems
5.2.1 North America
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.2.4 Middle East and Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle East and Africa
5.2.5 South America
220.127.116.11 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.3 etectRx Inc.
6.1.4 HQ Inc.
6.1.5 Jinshan Science and Technology
6.1.6 Koninklijke Philips N.V. (Medimetrics)
6.1.7 Medtronic PLC
6.1.8 Olympus Medical Technology
6.1.9 Otsuka Pharmaceutical Co. Ltd.
6.1.10 Proteus Pharmaceuticals
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/eq9lu7